SCHEMBL1670811

SCHEMBL1670811

CCOC(=O)OC1(N)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
SOAT1 P35610 1/20 0.46
ALOX15 P16050 3/20 0.41
GAA P10253 3/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
TRPA1 O75762 1/20 0.38
CYP1A2 P05177 1/20 0.38
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.32
ELANE P08246 1/20 0.32
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2355366 0.81 ALDH1A1 (0.36) ALDH1A1SOAT1ALOX15GAAMGAM
Hydrochloric Acid SCHEMBL1714512 0.79 ALDH1A1 (0.34) ALDH1A1SOAT1GAACYP1A2LMNA
SCHEMBL7932550 0.77 ALDH1A1 (0.55) ALDH1A1SOAT1ALOX15GAAMGAM
SCHEMBL13457064 0.76 ALDH1A1 (0.52) ALDH1A1SOAT1ALOX15GAAMGAM
SCHEMBL7595256 0.75
SCHEMBL12334684 0.74 ALDH1A1 (0.50) ALDH1A1SOAT1ALOX15GAAMGAM
SCHEMBL7058356 0.74 ALDH1A1 (0.50) ALDH1A1SOAT1ALOX15GAAMGAM
Hydrochloric Acid SCHEMBL9033761 0.73 NPSR1 (0.30)
SCHEMBL8308690 0.72 ALDH1A1 (0.48) ALDH1A1SOAT1ALOX15GAAMGAM
SCHEMBL14959847 0.72 ALDH1A1 (0.48) ALDH1A1SOAT1ALOX15GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0533832-B1 TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX US SECRETARY UNITED STATES DEP (US) 2002-11-20 EP claimed
EP-1778238-B1 DIHYDROPTERIDINONE INFUSION SOLUTION HAVING A LONG SHELF LIFE BOEHRINGER INGELHEIM INT (DE) 2011-10-12 EP disclosed
WO-2006018221-A9 DIHYDROPTERIDINONE INFUSION SOLUTION HAVING A LONG SHELF LIFE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-04-28 WO disclosed
EP-1599478-B1 DIHYDROPTERIDINONES, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS BOEHRINGER INGELHEIM PHARMA (DE) 2007-05-09 EP disclosed
EP-1778238-A1 DIHYDROPTERIDINONE INFUSION SOLUTION HAVING A LONG SHELF LIFE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-02 EP disclosed
WO-2006018221-A1 DIHYDROPTERIDINONE INFUSION SOLUTION HAVING A LONG SHELF LIFE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-02-23 WO disclosed
EP-1599478-A1 DIHYDROPTERIDINONES, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2005-11-30 EP disclosed
WO-2004076454-A1 DIHYDROPTERIDINONES, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO KG (DE) 2004-09-10 WO disclosed